NYSE:KDMN Kadmon - KDMN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Kadmon Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. $9.50 0.00 (0.00%) (As of 11/9/2021) Add Compare Share Share Today's Range$9.50▼$9.5050-Day Range$9.50▼$9.5052-Week Range$3.19▼$9.50Volume1,052 shsAverage Volume5.11 million shsMarket Capitalization$1.70 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsHeadlinesOptions ChainSocial Media About Kadmon (NYSE:KDMN) StockKadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.Read More Receive KDMN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kadmon and its competitors with MarketBeat's FREE daily newsletter. Email Address KDMN Stock News HeadlinesJanuary 24, 2023 | americanbankingnews.comKadmon (NYSE:KDMN) Earns Sell Rating from Analysts at StockNews.comSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive KDMN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kadmon and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE Industry Pharmaceutical Preparation Manufacturing Sub-IndustryN/A SectorManufacturing Current SymbolNYSE:KDMN CUSIPN/A CIKN/A WebN/A Phone12123086000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares178,521,000Free FloatN/AMarket Cap$1.70 billion OptionableOptionable BetaN/A Key CompetitorsBlackRock Capital Allocation TrustNYSE:BCATiShares Fallen Angels USD Bond ETFNASDAQ:FALNFirst Trust NASDAQ Technology Dividend Index FundNASDAQ:TDIViShares iBonds Dec 2024 Term Treasury ETFNASDAQ:IBTEFirst Trust Tactical High Yield ETFNASDAQ:HYLSView All Competitors KDMN Stock - Frequently Asked Questions How have KDMN shares performed in 2023? Kadmon's stock was trading at $9.50 at the beginning of the year. Since then, KDMN stock has increased by 0.0% and is now trading at $9.50. View the best growth stocks for 2023 here. What other stocks do shareholders of Kadmon own? Based on aggregate information from My MarketBeat watchlists, some companies that other Kadmon investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Organigram (OGI), KushCo (KSHB), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Pennsylvania Real Estate Investment Trust (PEI), Auxly Cannabis Group (CBWTF) and CNBX Pharmaceuticals (CNBX). When did Kadmon IPO? (KDMN) raised $101 million in an IPO on Wednesday, July 27th 2016. The company issued 5,600,000 shares at $16.00-$20.00 per share. Citigroup and Jefferies acted as the underwriters for the IPO and JMP Securities and H.C. Wainwright & Co. were co-managers. What is Kadmon's stock symbol? Kadmon trades on the New York Stock Exchange (NYSE) under the ticker symbol "KDMN." How do I buy shares of Kadmon? Shares of KDMN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Kadmon's stock price today? One share of KDMN stock can currently be purchased for approximately $9.50. How much money does Kadmon make? Kadmon (NYSE:KDMN) has a market capitalization of $1.70 billion. How can I contact Kadmon? Kadmon's mailing address is 450 E 29th St, New York, New York 10016-8367. The company can be reached via phone at 12123086000. This page (NYSE:KDMN) was last updated on 1/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.